272.2 MIXED HYPERLIPIDEMIA


Code Information

Diagnosis Code: 272.2

Short Description: Mixed hyperlipidemia

Long Description: Mixed hyperlipidemia

Code Classification:

  • Endocrine, nutritional and metabolic diseases, and immunity disorders (240–279)
    • Other metabolic disorders and immunity disorders (270-279)
      • 272 Disorders of lipoid metabolism
        • 272.2 Mixed hyperlipidemia

Code Version: 2015 ICD-9-CM


References to Index of Diseases and Injuries

The code 272.2 has the following ICD-9-CM references to the Index of Diseases and Injuries
  • Broad - see also condition
    • beta disease 272.2
  • Cholesterol
    • elevated (high) 272.0
      • with elevated (high) triglycerides 272.2
  • Cirrhosis, cirrhotic 571.5
    • xanthomatosis 272.2
    • xanthomatous (biliary) (see also Cirrhosis, biliary) 571.6
      • due to xanthomatosis (familial) (metabolic) (primary) 272.2
  • Diabetes, diabetic (brittle) (congenital) (familial) (mellitus) (severe) (slight) (without complication) 250.0
    • secondary (chemical-induced) (due to chronic condition) (due to infection) (drug-induced) 249.0
      • xanthoma 249.8 [272.2]
    • xanthoma 250.8 [272.2]
  • Disease, diseased - see also Syndrome
    • broad
      • beta 272.2
  • Dysbetalipoproteinemia (familial) 272.2
  • Elevation
    • cholesterol 272.0
      • with high triglycerides 272.2
    • triglycerides 272.1
      • with high cholesterol 272.2
  • Findings, (abnormal), without diagnosis (examination) (laboratory test) 796.4
    • cholesterol 272.9
      • high 272.0
        • with high triglycerides 272.2
    • triglycerides 272.9
      • high 272.1
        • with high cholesterol 272.2
  • High
    • cholesterol 272.0
      • with high triglycerides 272.2
    • triglycerides 272.1
      • with high cholesterol 272.2
  • Hyperbetalipoproteinemia (acquired) (essential) (familial) (hereditary) (primary) (secondary) 272.0
    • with prebetalipoproteinemia 272.2
  • Hypercholesterolemia 272.0
    • with hyperglyceridemia, endogenous 272.2
  • Hyperlipidemia 272.4
    • combined 272.2
    • group
      • C 272.2
    • mixed 272.2
  • Hyperlipoproteinemia (acquired) (essential) (familial) (hereditary) (primary) (secondary) 272.4
    • Fredrickson type
      • IIB 272.2
      • III 272.2
  • Lipoproteinemia (alpha) 272.4
    • broad-beta 272.2
    • floating-beta 272.2
  • Xanthelasma 272.2
    • eyelid 272.2 [374.51]
    • palpebrarum 272.2 [374.51]
  • Xanthelasmatosis (essential) 272.2
  • Xanthoma(s), xanthomatosis 272.2
    • with
      • hyperlipoproteinemia
        • type I 272.3
        • type III 272.2
        • type IV 272.1
        • type V 272.3
    • bone 272.7
    • craniohypophyseal 277.89
    • cutaneotendinous 272.7
    • diabeticorum 250.8 [272.2]
      • due to secondary diabetes 249.8 [272.2]
    • disseminatum 272.7
    • eruptive 272.2
    • eyelid 272.2 [374.51]
    • familial 272.7
    • hereditary 272.7
    • hypercholesterinemic 272.0
    • hypercholesterolemic 272.0
    • hyperlipemic 272.4
    • hyperlipidemic 272.4
    • infantile 272.7
    • joint 272.7
    • juvenile 272.7
    • multiple 272.7
    • multiplex 272.7
    • primary familial 272.7
    • tendon (sheath) 272.7
    • tuberosum 272.2
    • tuberous 272.2
    • tubo-eruptive 272.2

Crosswalk Information

The code 272.2 converts into the following ICD-10 code(s):
ICD-9 Code ICD-10 Code ICD-10 Description
272.2 Right Arrow E78.2 Mixed hyperlipidemia
This ICD-9 to ICD-10 data is based on the 2018 General Equivalency Mapping (GEM) files published by the Centers for Medicare & Medicaid Services (CMS) for informational purposes only. The data is not an ICD-10 conversion tool and doesn’t guarantee clinical accuracy.

Similar Codes

ICD-9 Code ICD-9 Description
272.0 Pure hypercholesterolemia
272.1 Pure hyperglyceridemia
272.3 Hyperchylomicronemia
272.4 Other and unspecified hyperlipidemia
272.5 Lipoprotein deficiencies
272.6 Lipodystrophy
272.7 Lipidoses
272.8 Other disorders of lipoid metabolism
272.9 Unspecified disorder of lipoid metabolism


This page was last updated on: 10/1/2014